Revance Therapeutics shares owned by Context Capital Management
Quarter-by-quarter ownership of Revance Therapeutics shares owned by Context Capital Management
from 13F filings
Historical chart of Context Capital Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Context Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $24B | 31M | 764.38 |
| 2023-09-30 | $15M | 18k | 807.37 |
| 2023-06-30 | $1.1M | 1.0k | 1059.00 |
| 2023-03-31 | $4.0M | 3.2k | 1231.46 |
| 2022-09-30 | $1.1M | 1.0k | 1085.00 |
| 2022-06-30 | $809k | 1.0k | 809.00 |
| 2022-03-31 | $951k | 1.0k | 951.00 |
| 2021-12-31 | $4.6M | 5.2k | 884.33 |
| 2021-09-30 | $6.9M | 6.0k | 1153.33 |
| 2021-06-30 | $24M | 20k | 1171.65 |
| 2021-03-31 | $28M | 25k | 1125.68 |
More positions owned by Context Capital Management
View all positions for Context Capital Management